COMPARATIVE EFFICACY AND SAFETY OF OZANIMOD AND ADALIMUMAB IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
Marla C. Dubinsky 1
1 Mount Sinai Hospital, Mount Sinai
Topic
Hepatobiliary, IBD, Primary Care
Conference
UEG Week Virtual 2021
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]
New to myUEG?
Social Sharing